Copyright Reports & Markets. All rights reserved.

Global Sulphonamides Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Sulphonamides Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Sulphonamides Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Sulphonamides Market Size Growth Rate by Type
    • 1.4.2 Orally Absorbable Sulfonamide
    • 1.4.3 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
    • 1.4.4 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
  • 1.5 Market by Application
    • 1.5.1 Global Sulphonamides Market Size Growth Rate by Application
    • 1.5.2 Skin Infections
    • 1.5.3 Gastro Intestinal Tract (GIT) Infection
    • 1.5.4 Meningitis
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Sulphonamides Market Size, Estimates and Forecasts
    • 2.1.1 Global Sulphonamides Revenue 2015-2026
    • 2.1.2 Global Sulphonamides Sales 2015-2026
  • 2.2 Global Sulphonamides, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Sulphonamides Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Sulphonamides Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Sulphonamides Competitor Landscape by Players

  • 3.1 Sulphonamides Sales by Manufacturers
    • 3.1.1 Sulphonamides Sales by Manufacturers (2015-2020)
    • 3.1.2 Sulphonamides Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Sulphonamides Revenue by Manufacturers
    • 3.2.1 Sulphonamides Revenue by Manufacturers (2015-2020)
    • 3.2.2 Sulphonamides Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Sulphonamides Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Sulphonamides Revenue in 2019
    • 3.2.5 Global Sulphonamides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Sulphonamides Price by Manufacturers
  • 3.4 Sulphonamides Manufacturing Base Distribution, Product Types
    • 3.4.1 Sulphonamides Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Sulphonamides Product Type
    • 3.4.3 Date of International Manufacturers Enter into Sulphonamides Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Sulphonamides Market Size by Type (2015-2020)
    • 4.1.1 Global Sulphonamides Sales by Type (2015-2020)
    • 4.1.2 Global Sulphonamides Revenue by Type (2015-2020)
    • 4.1.3 Sulphonamides Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Sulphonamides Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Sulphonamides Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Sulphonamides Revenue Forecast by Type (2021-2026)
    • 4.2.3 Sulphonamides Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Sulphonamides Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Sulphonamides Market Size by Application (2015-2020)
    • 5.1.1 Global Sulphonamides Sales by Application (2015-2020)
    • 5.1.2 Global Sulphonamides Revenue by Application (2015-2020)
    • 5.1.3 Sulphonamides Price by Application (2015-2020)
  • 5.2 Sulphonamides Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Sulphonamides Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Sulphonamides Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Sulphonamides Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Sulphonamides by Country
    • 6.1.1 North America Sulphonamides Sales by Country
    • 6.1.2 North America Sulphonamides Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Sulphonamides Market Facts & Figures by Type
  • 6.3 North America Sulphonamides Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Sulphonamides by Country
    • 7.1.1 Europe Sulphonamides Sales by Country
    • 7.1.2 Europe Sulphonamides Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Sulphonamides Market Facts & Figures by Type
  • 7.3 Europe Sulphonamides Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Sulphonamides by Region
    • 8.1.1 Asia Pacific Sulphonamides Sales by Region
    • 8.1.2 Asia Pacific Sulphonamides Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Sulphonamides Market Facts & Figures by Type
  • 8.3 Asia Pacific Sulphonamides Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Sulphonamides by Country
    • 9.1.1 Latin America Sulphonamides Sales by Country
    • 9.1.2 Latin America Sulphonamides Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Sulphonamides Market Facts & Figures by Type
  • 9.3 Central & South America Sulphonamides Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Sulphonamides by Country
    • 10.1.1 Middle East and Africa Sulphonamides Sales by Country
    • 10.1.2 Middle East and Africa Sulphonamides Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Sulphonamides Market Facts & Figures by Type
  • 10.3 Middle East and Africa Sulphonamides Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Corporation Information
    • 11.1.2 Abbott Laboratories Description and Business Overview
    • 11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbott Laboratories Sulphonamides Products Offered
    • 11.1.5 Abbott Laboratories Related Developments
  • 11.2 Boehringer Ingelheim Pharmaceuticals
    • 11.2.1 Boehringer Ingelheim Pharmaceuticals Corporation Information
    • 11.2.2 Boehringer Ingelheim Pharmaceuticals Description and Business Overview
    • 11.2.3 Boehringer Ingelheim Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Boehringer Ingelheim Pharmaceuticals Sulphonamides Products Offered
    • 11.2.5 Boehringer Ingelheim Pharmaceuticals Related Developments
  • 11.3 Bayer AG
    • 11.3.1 Bayer AG Corporation Information
    • 11.3.2 Bayer AG Description and Business Overview
    • 11.3.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Bayer AG Sulphonamides Products Offered
    • 11.3.5 Bayer AG Related Developments
  • 11.4 GlaxoSmithKline
    • 11.4.1 GlaxoSmithKline Corporation Information
    • 11.4.2 GlaxoSmithKline Description and Business Overview
    • 11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 GlaxoSmithKline Sulphonamides Products Offered
    • 11.4.5 GlaxoSmithKline Related Developments
  • 11.5 King Pharmaceuticals
    • 11.5.1 King Pharmaceuticals Corporation Information
    • 11.5.2 King Pharmaceuticals Description and Business Overview
    • 11.5.3 King Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 King Pharmaceuticals Sulphonamides Products Offered
    • 11.5.5 King Pharmaceuticals Related Developments
  • 11.6 Mylan Pharmaceuticals
    • 11.6.1 Mylan Pharmaceuticals Corporation Information
    • 11.6.2 Mylan Pharmaceuticals Description and Business Overview
    • 11.6.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Mylan Pharmaceuticals Sulphonamides Products Offered
    • 11.6.5 Mylan Pharmaceuticals Related Developments
  • 11.7 Novartis International AG
    • 11.7.1 Novartis International AG Corporation Information
    • 11.7.2 Novartis International AG Description and Business Overview
    • 11.7.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Novartis International AG Sulphonamides Products Offered
    • 11.7.5 Novartis International AG Related Developments
  • 11.8 Pfizer
    • 11.8.1 Pfizer Corporation Information
    • 11.8.2 Pfizer Description and Business Overview
    • 11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Pfizer Sulphonamides Products Offered
    • 11.8.5 Pfizer Related Developments
  • 11.9 Par Pharmaceutical
    • 11.9.1 Par Pharmaceutical Corporation Information
    • 11.9.2 Par Pharmaceutical Description and Business Overview
    • 11.9.3 Par Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Par Pharmaceutical Sulphonamides Products Offered
    • 11.9.5 Par Pharmaceutical Related Developments
  • 11.10 Roche Holding AG
    • 11.10.1 Roche Holding AG Corporation Information
    • 11.10.2 Roche Holding AG Description and Business Overview
    • 11.10.3 Roche Holding AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Roche Holding AG Sulphonamides Products Offered
    • 11.10.5 Roche Holding AG Related Developments
  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Corporation Information
    • 11.1.2 Abbott Laboratories Description and Business Overview
    • 11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbott Laboratories Sulphonamides Products Offered
    • 11.1.5 Abbott Laboratories Related Developments
  • 11.12 Stiefel Laboratories
    • 11.12.1 Stiefel Laboratories Corporation Information
    • 11.12.2 Stiefel Laboratories Description and Business Overview
    • 11.12.3 Stiefel Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Stiefel Laboratories Products Offered
    • 11.12.5 Stiefel Laboratories Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Sulphonamides Market Estimates and Projections by Region
    • 12.1.1 Global Sulphonamides Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Sulphonamides Revenue Forecast by Regions 2021-2026
  • 12.2 North America Sulphonamides Market Size Forecast (2021-2026)
    • 12.2.1 North America: Sulphonamides Sales Forecast (2021-2026)
    • 12.2.2 North America: Sulphonamides Revenue Forecast (2021-2026)
    • 12.2.3 North America: Sulphonamides Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Sulphonamides Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Sulphonamides Sales Forecast (2021-2026)
    • 12.3.2 Europe: Sulphonamides Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Sulphonamides Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Sulphonamides Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Sulphonamides Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Sulphonamides Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Sulphonamides Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Sulphonamides Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Sulphonamides Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Sulphonamides Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Sulphonamides Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Sulphonamides Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Sulphonamides Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Sulphonamides Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Sulphonamides Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Sulphonamides Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Sulphonamides Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Sulphonamides market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sulphonamides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Sulphonamides market is segmented into
    Orally Absorbable Sulfonamide
    Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
    Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)

    Segment by Application, the Sulphonamides market is segmented into
    Skin Infections
    Gastro Intestinal Tract (GIT) Infection
    Meningitis

    Regional and Country-level Analysis
    The Sulphonamides market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Sulphonamides market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Sulphonamides Market Share Analysis
    Sulphonamides market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sulphonamides business, the date to enter into the Sulphonamides market, Sulphonamides product introduction, recent developments, etc.

    The major vendors covered:
    Abbott Laboratories
    Boehringer Ingelheim Pharmaceuticals
    Bayer AG
    GlaxoSmithKline
    King Pharmaceuticals
    Mylan Pharmaceuticals
    Novartis International AG
    Pfizer
    Par Pharmaceutical
    Roche Holding AG
    Sanofi Aventis
    Stiefel Laboratories

    Buy now